PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Gene chip invented by CHOP scientist pinpoints new target to prevent heart disease

Anti-inflammatory drugs may offer novel treatment for heart disease, say gene researchers in large study

2012-03-15
(Press-News.org) A large international study indicates that anti-inflammatory drugs may become a new tool for preventing and treating coronary heart disease (CHD), the leading global cause of death. In investigating a specific gene variant linked to inflammation and heart disease, the researchers used the Cardiochip, a gene analysis tool designed by Brendan J. Keating, Ph.D., a researcher in the Center for Applied Genomics at The Children's Hospital of Philadelphia, and co-author of the study.

Scientists already knew that inflammation is associated with atherosclerosis, the buildup of fatty deposits on artery walls that causes CHD, but until now, no one had identified an inflammatory agent causing the disease. Likewise, it was unknown whether a drug targeted at reducing inflammation might treat CHD.

The current study focused on the interleukin-6 receptor (IL6R), a signaling protein found in the blood that increases inflammatory responses. "This study provides robust evidence that IL6R is implicated in coronary heart disease," said Keating. "Furthermore, our analysis showed that an existing anti-inflammatory drug, acting on this receptor, may offer a new potential approach for preventing CHD."

The study, which appeared online today in The Lancet, was performed by the IL6R Mendelian Randomisation Analysis Consortium, an international research team led by Dr. Juan Pablo Casas, Professor Aroon D. Hingorani, and Dr. Daniel I. Swerdlow, all of University College London in the U.K. The study was a meta-analysis of data from 40 existing studies that included nearly 133, 500 participants from the U.S. and Europe. Mendelian randomization is a research method that uses knowledge of genes and biological mechanisms to predict likely effects of a new drug before conducting a clinical trial, with its high cost and potential risk of side effects.

A companion study in the same issue of The Lancet, by the IL6R Genetics Consortium and Emerging Risk Factors Collaboration, found that a genetic variant in the IL6R gene, which carries the code for the IL6R protein, dials down inflammation and thus lowers the risk of heart disease.

The study in which Keating participated focused on SNPs (single nucleotide polymorphisms) single-base changes in the IL6R gene that codes for the IL6R protein.

Among the research team's tools was a DNA array, the IBC Human CVD BeadChip, also called the Cardiochip, created by Keating in 2006 and since used in many large gene studies. That chip contains DNA markers for 2000 gene variants implicated in cardiovascular disease. When brought into contact with test samples of DNA from research participants, the chip detects specific SNPs in the sample —gene variants that may affect biological functions and risks of heart disease among the participants.

They found that one SNP, the gene variant rs8192284, altered several biological markers associated with inflammation. Those results were similar to those found in trials of tocilizumab, an anti-inflammatory drug currently used to treat rheumatoid arthritis. By inhibiting the action of IL6R, this drug reduces the painful inflammation common in rheumatoid arthritis.

Further analysis of data from CHD patients and controls showed that subjects carrying the gene variant had a lower risk of CHD. "What this tells us is that IL6R blockers such as tocilizumab mimic the benefits of having this gene variant," said Keating. "A next step will be for cardiology researchers to design and carry out clinical trials to determine whether tocilizumab or similar anti-inflammatory drugs will prevent heart disease."

INFORMATION:

More than 30 organizations and agencies funded this study, including the U.K. Medical Research Council, the British Heart Foundation, the National Institutes of Health and the Wellcome Trust. A senior investigator from The Children's Hospital of Philadelphia, Hakon Hakonarson, M.D., Ph.D., director of the Hospital's Center for Applied Genomics, was among the co-authors who interpreted findings and wrote the report.

"The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomization analysis," The Lancet, published online March 14, 2012, doi:10.1016/S0140-6736(12)60110-X

About The Children's Hospital of Philadelphia: The Children's Hospital of Philadelphia was founded in 1855 as the nation's first pediatric hospital. Through its long-standing commitment to providing exceptional patient care, training new generations of pediatric healthcare professionals and pioneering major research initiatives, Children's Hospital has fostered many discoveries that have benefited children worldwide. Its pediatric research program is among the largest in the country, ranking third in National Institutes of Health funding. In addition, its unique family-centered care and public service programs have brought the 516-bed hospital recognition as a leading advocate for children and adolescents. For more information, visit http://www.chop.edu.

END



ELSE PRESS RELEASES FROM THIS DATE:

Beating heart surgery may increase risk to patients

2012-03-15
Coronary artery bypass surgery performed whilst the heart is still beating may carry an increased likelihood of death, according to a systematic review by Cochrane researchers. The researchers suggest beating heart surgery should not be recommended except in specific cases where stopping the heart might be risky. Heart surgery in patients with heart disease caused by narrowed arteries has for many years been performed "on-pump", by stopping the heart and introducing a bypass to artificially pump the patient's blood. It is now possible to perform surgery without stopping ...

Hiding in plain sight, a new frog species with a 'weird' croak is identified in New York City

2012-03-15
In the wilds of New York City — or as wild as you can get so close to skyscrapers — scientists have found a new leopard frog species that for years biologists mistook for a more widespread variety of leopard frog. While biologists regularly discover new species in remote rain forests, finding this one in the ponds and marshes of Staten Island, mainland New York and New Jersey — sometimes within view of the Statue of Liberty — is a big surprise, said the scientists from UCLA, Rutgers University, UC Davis, and The University of Alabama who worked together to make the unexpected ...

'Brain fog' of menopause confirmed

2012-03-15
The difficulties that many women describe as memory problems when menopause approaches are real, according to a study published today in the journal Menopause, the journal of the North American Menopause Society. The findings won't come as a surprise to the millions of women who have had bouts of forgetfulness or who describe struggles with "brain fog" in their late 40s and 50s. But the results of the study, by scientists at the University of Rochester Medical Center and the University of Illinois at Chicago who gave women a rigorous battery of cognitive tests, validate ...

Genetic profiling can help doctors more accurately predict prognosis and guide treatment decisions for leukemia patients

2012-03-15
NEW YORK, MARCH 14, 2012 – Researchers have identified a set of genetic abnormalities in patients with acute myelogenous leukemia (AML) that doctors can use to more accurately predict patients' prognoses and select treatments that are most likely to benefit them. The study, led by investigators at Memorial Sloan-Kettering Cancer Center, will be published in the March 22 issue of the New England Journal of Medicine. "Our study shows that genetic profiling makes it possible to more precisely categorize which patients are most likely to have their leukemia return after treatment," ...

Are silver nanoparticles harmful?

2012-03-15
Silver nanoparticles cause more damage to testicular cells than titanium dioxide nanoparticles, according to a recent study by the Norwegian Institute of Public Health. However, the use of both types may affect testicular cells with possible consequences for fertility. Commonly used Nanotechnology is increasingly used in consumer products, medicines and building products. The potential risks of using engineered nanoparticles need to be monitored so that the industry can develop products that are safe for humans and nature. Previous research has shown that nanoparticles ...

Atlanta Exterminators North Fulton Pest Solutions Encourage Atlanta Termite Control in Spring

2012-03-15
Atlanta pest control company North Fulton Pest Solutions encourages homeowners as well as business owners to schedule termite inspections and treatments for the spring. Spring is the breeding season (or "swarm season") for termites, so a well-scheduled Atlanta termite treatment can help stop an infestation before it starts or becomes worse. "Spring is a prime time for termite treatments in Atlanta," says Blake Edwards, Director of Business Development for North Fulton Pest Solutions. "Termites swarm and breed in spring, creating new colonies ...

In developing countries, female sex workers 14 times more likely to become infected by HIV

2012-03-15
Female sex workers in low- and middle-income countries are nearly 14 times more likely to be infected by HIV compared to the rest of country's population, according to an analysis by researchers at the Johns Hopkins Bloomberg School of Public Health. The findings suggest an urgent need to scale up access to quality HIV prevention programs in these countries. The study was published online in The Lancet Infectious Diseases. "Although female sex workers have long been understood to be a key affected population, the scope and breadth of their disproportionate risk for HIV ...

New study shows promise for developing new treatments for breast cancer

2012-03-15
LEXINGTON, Ky. (March 14, 2012) — A new study by University of Kentucky researchers provides insight into developing new treatment strategies for basal-like breast cancer, commonly known as triple-negative breast cancer. This cancer is associated with early metastasis and resistance to chemotherapy and occurs at women at a younger age. Tumor cells can exploit a cellular program that promotes cell migration and reduces adhesion between cells to spread to distant sites in the body. This cellular program, known as the epithelial-mesenchymal transition, requires large-scale ...

Combined therapy of acne medications offers new treatment option for patients

Combined therapy of acne medications offers new treatment option for patients
2012-03-15
DETROIT – A combined therapy of common acne medications was shown to be a potent regimen for treating patients with severe facial acne, according to two published studies involving Henry Ford Hospital. The companion studies found that a therapy of the topical Epiduo Gel containing adapalene and benzoyl peroxide and the antibiotic doxycycline proved more effective at reducing acne lesions compared to other treatment regimens. Of the 459 patients involved in the study, 76 percent of those who received the regimen of Epiduo Gel and doxycycline as initial therapy for ...

Atlanta Movers A.C. White Relocations Reminds Homeowners to Book Atlanta Moving Companies Early

Atlanta Movers A.C. White Relocations Reminds Homeowners to Book Atlanta Moving Companies Early
2012-03-15
Atlanta moving company A.C. White Relocations reminds homeowners to reserve a slot with Atlanta movers early for the busy summer moving season. If you are planning to move this summer, you need to start contacting Atlanta moving companies as soon as possible. Truck drivers in the Atlanta moving industry have been in short supply over the past few years, so movers in Atlanta like A.C. White Relocations tend to book up quickly during the busy summer months. Often if Atlanta homeowners wait until even a couple of months in advance, they may find the majority or even all ...

LAST 30 PRESS RELEASES:

Signs identified that precede sudden arrhythmic death syndrome in young people

Discovery of bacteria's defence against viruses becomes a piece of the puzzle against resistance

Pre-eclampsia is associated with earlier onset and higher incidence of cardiovascular risk factors

Warwick astronomers discover doomed pair of spiralling stars on our cosmic doorstep

Soil conditions significantly increase rainfall in world’s megastorm hotspots

NK cells complexed with bispecific antibody yield high response rates in patients with lymphoma

Planetary health diet and mediterranean diet associated with similar survival and sustainability benefits

Singapore launches national standard to validate antimicrobial disinfectant products

Molecular stool test could improve detection of tuberculosis in adults with HIV

Suspected fibrocartilaginous embolus in Asian small-clawed otter (Aonyx cinereus)

Enhancing heat transfer using the turbulent flow of viscoelastic fluids

Exercise as an anti-ageing intervention to avoid detrimental impact of mental fatigue

UMass Amherst Nursing Professor Emerita honored as ‘Living Legend’

New guidelines aim to improve cystic fibrosis screening

Picky eaters by day, buffet by night: Butterfly, moth diets sync to plant aromas

Pennington Biomedical’s Dr. Leanne Redman honored with the E. V. McCollum Award from the American Society for Nutrition

CCNY physicists uncover electronic interactions mediated via spin waves

Researchers’ 3D-printing formula may transform future of foam

Nurture more important than nature for robotic hand

Drug-delivering aptamers target leukemia stem cells for one-two knockout punch

New study finds that over 95% of sponsored influencer posts on Twitter were not disclosed

New sea grant report helps great lakes fish farmers navigate aquaculture regulations

Strain “trick” improves perovskite solar cells’ efficiency

How GPS helps older drivers stay on the roads

Estrogen and progesterone stimulate the body to make opioids

Dancing with the cells – how acoustically levitating a diamond led to a breakthrough in biotech automation

Machine learning helps construct an evolutionary timeline of bacteria

Cellular regulator of mRNA vaccine revealed... offering new therapeutic options

Animal behavioral diversity at risk in the face of declining biodiversity

Finding their way: GPS ignites independence in older adult drivers

[Press-News.org] Gene chip invented by CHOP scientist pinpoints new target to prevent heart disease
Anti-inflammatory drugs may offer novel treatment for heart disease, say gene researchers in large study